Recall due to decreased dexpanthenol concentrations

Up-to-date information from the 07.11.-11.11.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Recall due to increased complaints regarding discoloured solution

Absence of the pipette in the package

Up-to-date information from the 10.10.-13.10.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the 12.09-15.09.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that 1 additional human WNV infection has been recorded in Germany.

Recall due to yellowish discolouration of the solution

i-SPOC registration has been mandatory since September 2, 2022 and applies to all pharmaceutical companies with a centrally- or nationally-authorised human medicinal product in the EU.

Batch recall due to possible product mix